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Sedation for fibre optic bronchoscopy 
J. H. GREIG*, S. M. COOPER, H. J. N. KASIMBAZI, R. D. H. MONIE, A. G. FENNERTY AND 
B. WATSON 
The Chest Clinic, Southern General Hospital, Glasgow, U.K. 
Most current sedative regimens for fibre optic bronchoscopy use an opioid, a benzodiazepine or a 
combination of both. This study compares midazolam (M) (a.benzodiazepine), alfentanil (A) (an opioid) and 
a combination of both drugs (M+A). 
One hundred and three patients were randomized in double-blind manner into groups M(3-9, A(33) and 
M +A(35). The number of coughs, number of additional aliquots of lignocaine and duration of the procedures 
were recorded along with oxygen desaturation. The patient’s level of discomfort was assessed by patient and 
bronchoscopist and expressed as a visual analogue score. 
There were significantly fewer coughs per minute in Group A compared with Group M (P=O.O053), and 
significantly less lignocaine was required in Group A (P=O.OOS) and in Groups M +A (P<O.O02) compared 
with Group M. There was no significant difference in the assessment of discomfort between the groups. There 
was a trend for Group M+A to desaturate more than the other two with a significant difference between 
desaturation in Group M+A and Group A (P=O.O33). 
Alfentanil is a more effective anti-tussive agent than midazolam for outpatient fibre optic bronchoscopy. 
The combination of alfentanil and midazolam does not provide any better anti-tussive effect and may have the 
risk of a greater degree of desaturation secondary to increased sedation. 
Introduction 
Fibre optic bronchoscopy in the U.K. is usually 
performed with some form of sedation (1). Sixty per 
cent of patients in one study found bronchoscopy 
without sedation unpleasant or intolerable (2). 
Ideally sedation should be safe, free from side- 
effects and have anxiolytic, amnesic and anti-tussive 
qualities. The choice of agents varies but usually a 
benzodiazepine, an opioid or a combination of both 
are used (3). 
This study compares midazolam (M), a benzodiaz- 
epine with a very short half-life and alfentanil (A), 
an opioid which is rapidly metabolized to inactive 
products, and a combination of both drugs (M+A) 
as sedation for outpatient bronchoscopy. 
Methods 
Consecutive patients attending for outpatient 
bronchoscopy were randomized, after giving written 
and informed consent, to receive one of three variet- 
ies of sedation; none was given prior premeditation. 
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Group M received intravenous midazolam titrated 
according to weight (2 mg if 50-60 kg, 3 mg if 
60-70 kg, 4 mg if 70 kg+), with intravenous saline as 
placebo (1 ml). Additional midazolam was titrated if 
initial sedation was inadequate. 
Group A received intravenous alfentanil 
(0.5 mg ml- ‘) with intravenous saline as placebo 
(dose titrated according to weight as if midazolam). 
Additional alfentanil was titrated if initial sedation 
was inadequate (0.25 mg aliquots). 
Group M +A received intravenous alfentanil 
(0.5 mg ml ‘), intravenous midazolam (dose titrated 
according to weight) with additional midazolam if 
initial sedation was inadequate. 
All patients therefore received two injections; 
either saline placebo and active drug or two active 
drugs. The syringes were made up by one unblinded 
author. Two authors only gave the sedation 
remaining blind and performed all bronchoscopies. 
All drugs were injected slowly through an intra- 
venous cannula, Venflon (Viggo Spectromed) which 
remained in situ during the bronchoscopy. All 
patients also received intravenous atropine (0.6 mg), 
and lignocaine 4% (1 ml) via transcricoid membrane 
injection, and (1 ml) through the bronchoscope once 
in the trachea. Additional aliquots of lignocaine 
2% (2 ml) were given through the bronchoscope 
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Table 1 
M M+A A 
Number 34 33 35 
Sedation 
Midazolam Average 5.7 mg Average 4.5 mg - 
Range 2-10 mg Range 2-10 mg 
Alfentamil 0.5 mg Average 0.66 mg 
Range 0.05-l mg 
Duration of procedure Average 5.5 min Average 7.5 min Average 5.9 min 
(from insertion of bronchoscope Range 5-15 min Range 2-19 min Range 1.5-12 min 
to removal) 
during the procedure for troublesome coughing. Full 
resuscitation equipment was available in the bron- 
choscopy suite, along with the antidotes, flumazenil 
and naloxone to counteract both sedatives. Oxygen 
was available and oxygen saturation measured by a 
pulse oximeter (Satlite Trans. Dantex) which was 
attached to an index finger. 
The duration of the procedure, number of coughs 
and extra aliquots of lignocaine required for each 
patient were recorded by one independent observer. 
After the procedure the level of discomfort experi- 
enced as perceived by both patient and bronchos- 
copist was charted on a 10 cm visual analogue scale. 
This was then expressed as a percentage with 100% 
score equal to no discomfort. 
The recovery time was assessed by the ability of the 
patient to obey some simple commands (e.g. open 
eyes or mouth). 
Comparisons were made for each measurement 
between the three groups, i.e. Group M, Group A 
and Group M+A. As the parameters measured were 
not normally distributed, all comparisons were made 
using the Mann-Whitney U-test. 
The study was given approval by the Hospital 
Ethics Committee. 
Results 
One hundred and three patients were randomized: 
34 randomized to Group M, 35 to Group A and 33 to 
Group M+A. The amount of sedation given to each 
group is shown in Table 1. 
There were significantly fewer coughs mini ’ in 
Group A compared with Group M (P=O.O053) and 
Group M required more additional aliquots of 
lignocaine compared with Group A (NO.005) and 
Group M+A (P<O.O02). 
The oxygen saturation fell significantly more in 
Group M+A compared with Group A (P=O.O037) 
and appeared to fall more in Group M + A compared 
with Group M though not to a significant degree. 
There was no significant difference between the bron- 
choscopist or patient’s perception of discomfort 
between the three groups (Table 2). 
Recovery time was immediate, all patients being 
able to respond to simple commands at the end of the 
procedure and were able to return home within 2 h. 
Discussion 
Fibre optic bronchoscopy is now routinely per- 
formed as an outpatient procedure. It is therefore 
important that sedation is optimal with good anxio- 
lytic, amnesic and anti-tussive qualities and of short 
duration of action. From the bronchoscopist’s point 
of view, control of coughing is particularly important 
as this facilitates ease of viewing the bronchial tree 
and of obtaining good biopsy material. 
Midazolam and alfentanil were selected for this 
study as both appeared to meet the above criteria. 
Midazolam is a sedative drug with amnesic qualities 
which has a rapid 2 h half-life and is metabolized to 
inactive products, unlike diazepam which is metabo- 
lized to desmethyldiazepam prolonging its action. 
Alfentanil is an opioid and therefore has theoretical 
anti-tussive action. It is a synthetic derivative of 
fentanyl which is 5-10 times less potent than 
fentanyl. It has a very short duration of action with 
peak effect in 90 s and duration of action only 
5-10 min (onset of action four times more rapid and 
a third the duration of fentanyl). There is however 
the risk of dose-related respiratory depression and 
occasional unpredictable effects have been noted so 
patients should be observed for 2 h post dose. 
Alfentanil proved to have significantly better anti- 
tussive qualities than midazolam as shown by both 
the reduced cough count and reduced lignocaine 
requirements. There was a trend for the bronchos- 
copist to perceive the patient to be more comfortable 
with alfentanil, presumably due to the fact that they 
Sedation for fibre optic bronchoscopy 55 
Table 2 
M M+A A Significance 
Coughs min - ’ 
Lignocaine 
(No. of aliquots) 
Additional 
Visual Analogue Score 
(bronchoscopist) 
Visual Analogue Score 
(patient) 
Minimum % drop in 0, saturation 
245 f 167 1.72 SI 1.28 1.42 & 1.67 MvA 
P=O.O053 
0.79 f 0.6 0.34 f 0.59 0.37 f 0.55 AvM 
PCO.005 
M+AvM 
I-o.002 
54.5% f 30.9 72.9% f 26.3 79.9% f 19.8 NS 
88.2% f 13.6 86% f 24.9 12% zk 32.1 NS 
9.6% f 4.5 13.5% i 9.1 8.6% f 6.2 M+AvA P=O.O33 
MvA NS 
M+AvM NS 
coughed less making the procedure easier. One would 
have expected the patients who received midazolam 
to have reported less discomfort due to its amnesic 
qualities. There appeared to be a slight trend in this 
direction but not as pronounced as the trend of 
the bronchoscopist’s perception of the patient’s 
discomfort. 
There have been numerous previous studies com- 
paring a variety of sedative regimes. Simpson’s postal 
study of bronchoscopic practice (1) revealed that 40% 
of doctors in the U.K. used a benzodiazepine and 
20% use a combination of opiate and benzodiazepine, 
but evidence for the effectiveness of the different 
combinations is confusing. Diazepam has been com- 
pared to morphine as premeditation for gastroscopy 
(4), diazepam being preferred because of increased 
sedation and amnesia, although the degree of coop- 
eration of patients was not significantly different 
between the groups. Numerous studies have com- 
pared midazolam with diazepam (5-9) and in most 
cases, midazolam was preferred, usually because of 
greater amnesic effect. Some authors felt drowsiness 
was excessive but in these cases very large doses of 
midazolam (up to 20 mg) were used. Diazepam and 
fentanyl in combination were thought to be more 
effective than papaveretum and hyoscine (lo), but all 
measurements were based on a questionnaire com- 
pleted by patients and no objective parameters were 
studied. Two studies have considered anti-tussive 
qualities. Temazepam was compared with papavere- 
turn (11) but no formal measurements were recorded, 
doctors merely giving a subjective assessment of the 
frequency of coughing following the procedure. 
There was no significant difference between the two 
drugs. A more useful study compared relatively light 
sedation with alfentanil with the deeper sedation of 
papaveretum combined with diazepam (12). A sig- 
nificant reduction in cough count was noted in the 
alfentanyl group, whilst as in this study, there was no 
significant difference in the level of discomfort as 
assessed by patients using a visual analogue scale 
between the two groups. 
The safety of any sedation is of paramount 
importance. A postal study (1) showed nationwide 
mortality due to fibre optic bronchoscopy to be 
0.04% and incidence of major complications to be 
0.12% (i.e. 44 from 34 462 of which 12 patients had 
respiratory depression). In our study, all patients 
desaturated as expected during routine bronchos- 
copy. It has been shown that fibre optic bronchos- 
copy alone can result in a fall of P,O, by up to 
21 mmHg (13). Those who received the combination 
of midazolam and alfentanil had a significantly 
greater drop in oxygen saturation when compared 
with each drug given singly. There was no significant 
difference in the fall of oxygen saturation between the 
midazolam and alfentanil groups alone and it is likely 
that the fall in oxygen saturation with the combi- 
nation (M+A) was due to a larger total dose of 
sedative drugs. 
Since one of the aims of this study was to assess 
the effect of sedation on oxygen saturation, oxygen 
was not routinely given despite marked desatu- 
ration in some patients, although oxygen was always 
available. It is now our practice to monitor all 
procedures with pulse oximetry and provide supple- 
mental oxygen via a nasal cannula to patients who 
desaturate. 
In conclusion this study confirms previous find- 
ings that alfentanil provides adequate sedation for 
outpatient fibre optic bronchoscopy while combining 
more effective anti-tussive effects than midazolam. 
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The combination of alfentanil and midazolam does 
not provide significantly better sedation in terms of 
patients perceived discomfort, at a cost of greater risk 
of oxygen desaturation due to the larger total dose of 
sedation. 
Finally, despite the apparent good safety profile of 
the alfentanil, we still feel that fibre optic bronchos- 
copy should be carried out in the presence of full 
resuscitative equipment, including antidotes. 
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